Global Allergy Diagnostics Market 2022

DUBLIN, June 24, 2022 /PRNewswire/ — “Allergy Diagnostics Global Market Report 2022, By Allergen, By Products, By End User” has been added to from offer.


The global allergy diagnostics market is expected to grow from $4.62 billion in 2021 for $5.07 billion in 2022 at a compound annual growth rate (CAGR) of 9.78%. The market should reach $7.50 billion in 2026 at a CAGR of 10.30%.

The allergy diagnostics market consists of the sale of allergy diagnostic solutions by entities (organizations, individual traders, and partnerships) that are used to identify the allergen (substance causing an allergic reaction) in a human body. An allergy is a reaction of the immune system to an allergen that is not normally harmful to the human body. Allergens are foreign substances that cause allergic reactions.

Certain foods like peanuts, milk, eggs and wheat, pollen and animal dander are some examples of allergens. Allergy diagnosis is a procedure used by a trained allergist to assess whether the body is allergic to a certain substance. A blood test, skin test, or elimination diet may be used as part of the examination. The diagnostic procedure for allergies depends on the type of allergens and the mode of transmission.

The main types of allergy diagnostic tests are in vivo allergy testing and in vitro allergy testing. In vivo allergy tests are performed on the human body to identify the cause of the allergic reaction. In vitro allergy tests are carried out on laboratories using test tubes and petri dishes to identify the substance causing the allergy.

Major allergy diagnostic products include consumables, instruments and luminometers. By allergens, the allergy diagnostics market is segmented into inhalant allergens, food allergens, and drug allergens. Major end users of allergy diagnostics include diagnostic laboratories, hospital laboratories, and academic and research institutes. North America was the largest region in the allergy diagnostics market in 2021.

The increase in the occurrence of allergic diseases will propel the growth of the allergy diagnostics market. The increase in allergic diseases has been attributed to the increase in environmental pollution due to traffic and many industries. An allergic reaction is described as an abnormal immune system response to an allergen. Allergic diseases include anaphylaxis, allergic rhinitis (often called “hay fever”), food allergies, skin allergies, and allergic asthma.

Avoiding allergens is the most essential treatment for allergic disorders. Therefore, proper allergy diagnosis is crucial for effective allergy treatment. For example, according to the EuroPrevall community survey report, in 2019 the prevalence of probable food allergies in adults was 0.3%, 1.4%, 2.1%, 2.8%, 3.3% and 5.6% in Athens, Reykjavík, UtrechtLodz, Madridand Zürich in 2019.

The most common allergy symptoms were oral allergy symptoms (81.6%), followed by skin allergy symptoms (38.2%) and rhinoconjunctivitis (29.5%). Thus, the increase in the prevalence of allergic diseases will further support the growth of the allergy diagnostics market.

The increase in the number of collaborations and partnerships between companies operating in the allergy diagnostics industry to invent new testing methods or improve existing ones is a recent market trend. For example, in July 2019PerkinElmer, Inc. and EverlyWell, Inc. announced a new partnership to accelerate innovation and accessibility of consumer-initiated health testing by integrating PerkinElmer’s CLIA and CAP-certified laboratory facilities into the provider network of EverlyWell Laboratories.

PerkinElmer provides the knowledge behind EverlyWell’s panels for Lyme disease and food sensitivity testing, which are the first products to emerge from this collaboration. Both tests use dried blood drop tests, which have been used by doctors and hospitals for decades to identify biomarkers of disease with just a few drops of blood. They were developed by medical geneticists board-certified by PerkinElmer Genomics and validated on the EUROIMMUN EUROBlotOne and EUROIMMUN AnalyzerTM systems.

In October 2021, IMA Group, a physician-founded network of integrated clinical research sites specializing in Phase II-IV clinical trials in multiple therapeutics, announced the acquisition of Diagnostics Research Group for an undisclosed amount. The acquisition gave IMA access to a wider range of patient populations and allows it to expand into the South West United States.

It also expands IMA’s clinical research division and its network of more than 90 physical medical practices. Diagnostics Research Group (DXRG) is a clinical research site based in San Antonio, TXwith expertise in vaccine and medical device development, internal medicine, allergy, and fatty liver and lung disease.

The countries covered in the Allergy Diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South KoreaUK, UNITED STATES.

Main topics covered:

1. Summary

2. Characteristics of the Allergy Diagnostics Market

3. Allergy Diagnostics Market Trends and Strategies

4. Impact of COVID-19 on allergy diagnosis

5. Allergy Diagnostics Market Size and Growth
5.1. Global Historic Allergy Diagnostics Market, 2016-2021, USD Billion
5.1.1. Market Drivers
5.1.2. Market Constraints
5.2. Global Allergy Diagnostics Market Forecast, 2021-2026F, 2031F, Billion USD
5.2.1. Market Drivers
5.2.2. Market Constraints

6. Allergy Diagnostics Market Segmentation
6.1. Global Allergy Diagnostics Market, Segmentation by Test Type, History & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

  • In vivo allergy testing

  • In vitro allergy tests

6.2. Global Allergy Diagnostics Market, Segmentation by Allergen, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

  • Inhaled allergens

  • Food allergens

  • Drug allergens

6.3. Global Allergy Diagnostics Market, Segmentation by Products, History and Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

  • Consumables

  • Instruments

  • Luminometers

6.4. Global Allergy Diagnostics Market, Segmentation by End User, History and Forecast, 2016-2021, 2021-2026F, 2031F, Billion USD

7. Regional and Country Analysis of the Allergy Diagnostics Market
7.1. Global Allergy Diagnostics Market, Split by Region, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion
7.2. Global Allergy Diagnostics Market, Split by Country, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

Companies cited

  • BioMérieux SA

  • Danaher Corporation

  • HOB Biotech Group Corp. ltd.

  • HYCOR Biomedical

  • Lincoln Diagnostics Inc.

  • Omega Diagnostics Group Plc.

  • Siemens Healthineers AG

  • Thermo Fischer Scientific Inc.

  • PerkinElmer Inc. (Euroimmun AG)

  • R-Biopharm AG

  • Alcon Laboratories Inc.

  • Abbott Laboratories

  • HollisterStier Allergy

  • NEOGEN Corporation


  • ACON Laboratories

  • Erba Group

  • Astra Biotech GmbH

For more information about this report visit

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716



View original content:—rise-in-the-number-of-collaborations-and-partnerships-among-companies – 301574804.html

SOURCE Research and Markets